Leupeptin inhibits the transformation of glucocorticoid receptor.
The effect of leupeptin upon the transformation of the glucocorticoid receptor was tested. When the labeled receptor was treated with heat or high salt in the presence of leupeptin, the binding to DNA-cellulose decreased in a dose-dependent manner. We observed 50% inhibition with about 40 mM leupeptin. The addition of leupeptin after the transformation procedures did not inhibit the binding to DNA-cellulose. In gradient centrifugation, 40 mM leupeptin retained approximately 10S, untransformed form. Elution profiles from DEAE-cellulose showed the preservation of the peak eluted with 0.2 M KCl, corresponding to the untransformed form. These results indicate that leupeptin might have the similar effects to molybdate in regard to blocking the transformation of rat liver glucocorticoid receptor, though the effects with leupeptin were not as great as those seen with molybdate.
Kasayama
S
S
Third Department of Internal Medicine, Osaka University Hospital, Japan.
Noma
K
K
Sato
B
B
Nakao
M
M
Nishizawa
Y
Y
Matsumoto
K
K
Kishimoto
S
S
D000315:Adrenalectomy; D000818:Animals; D002482:Cellulose / Q000031:analogs & derivatives; D002499:Centrifugation, Density Gradient; D002846:Chromatography, Affinity; D003600:Cytosol / Q000378:metabolism; D004247:DNA / Q000031:analogs & derivatives; D007700:Kinetics; D007976:Leupeptins / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008982:Molybdenum / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D014222:Triamcinolone Acetonide / Q000378:metabolism
C033190:DNA-cellulose; D007976:Leupeptins; D009842:Oligopeptides; D011965:Receptors, Glucocorticoid; C044659:molybdate; D008982:Molybdenum; D002482:Cellulose; D004247:DNA; D014222:Triamcinolone Acetonide; C032854:leupeptin